New care model aims to save lives of drug users with severe infections

NCT ID NCT05688423

Ongoing Disease control Sponsor: Columbia University Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether a special care team that combines treatment for severe injection-related infections and substance use disorders can improve outcomes. 480 hospitalized adults who inject drugs will either receive this integrated care or usual treatment. The main goal is to see if the integrated approach lowers death rates and hospital readmissions within 4 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Integrated care team (behavioral intervention combining infectious disease and substance use disorder treatment)
What this could lead to: If successful, this approach could reduce deaths and hospital readmissions for people with severe injection-related infections and substance use disorders.
What could go wrong: This is a single study with 480 participants, and results may not apply to all hospitals or patients. The intervention is complex and may be hard to replicate widely.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for INJECTION SITE INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Harm Reduction substance-related disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

INJECTION SITE INFECTION SUBSTANCE USE DISORDERS

Contacts and locations

Locations

Tampa General Hospital

Tampa, Florida, 33601, United States
University of Alabama at Birmingham

Birmingham, Alabama, 35294, United States
University of Miami - Jackson Memorial Hospital

Miami, Florida, 33136, United States
University of New Mexico Health Sciences Center

Albuquerque, New Mexico, 87106, United States
University of Pennsylvania

Philadelphia, Pennsylvania, 19104, United States
University of Utah Hospital

Salt Lake City, Utah, 84132, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.